Actos Trial Underway Seeking $1 Billion for Bladder Cancer: Now, AttorneyOne Can Provide Advice

Last week an Actos trial began in Clark County Courts - Eighth Circuit Court of Nevada where two plaintiffs allege that suffered bladder cancer from Actos. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Actos side effects.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Actos: serious adverse events

Actos: serious adverse events

According to the lawsuit, the two women suffered bladder cancer from Actos

San Diego, CA (PRWEB) March 18, 2014

AttorneyOne.com, a recognized authority on law, updated the website recently and now, can actively provide an expert opinion in view of the recent news on Actos Problems and lawsuits.

Last week an Actos trial began in Clark County Courts - Eighth Circuit Court of Nevada (case no. A-13-680556-C) where two plaintiffs allege that suffered bladder cancer from Actos. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. According to the lawsuit, the two women suffered bladder cancer from Actos and both have undergone multiple surgeries to remove tumors.

A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder cancer (ePub ahead of print, December 2013). Conclusions of the study include that “A modest but clinically significant increased risk of bladder cancer with pioglitazone was found that appears related to cumulative dose and duration of exposure.”

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in cases of severe complications, allegedly from Actos. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Actos lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On January 27, a federal Judge ruled that Takeda acted in “bad faith” and destroyed relevant evidence to the Actos Multidistrict Litigation [IN RE: Actos (Pioglitazone) Products Liability Litigation, MDL 2299, US District Court for the Western District of Louisiana]. According to the documents, the Court concluded “relevant evidence was deleted by Takeda after the duty to preserve such evidence arose”. Court data updated by the Judicial Panel on Multidistrict Litigation on March 13, indicate that there are 2,923 cases pending in the Actos Multidistrict Litigation.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/03/prweb11674451.htm